Clinical Trial Update: A Clinical Study: the Antibacterial Effect of Insoluble Antibacterial Nanoparticles (IABN) Incorporated in Dental Materials for Root Canal Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the antibacterial effect of insoluble antibacterial nanoparticles (IABN) incorporated into dental materials for root …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Endodontic Treatment, Irreversible Pulpitis | Phase 2 | Status: UNKNOWN